AMERICAN VIETNAMESE BIOTECH INCORPORATION

American Vietnamese Biotech Incorporation

AMV

VN000000AMV5

Pharmaceuticals

End-of-day quote HANOI S.E. Other stock markets 03:30:00 23/05/2024 am IST			5-day change	1st Jan Change
3,600 ^VND	+2.86%		+5.88%	-7.69%

06/05	American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/02	American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

An undisclosed buyer acquired 5.28% stake in American Vietnamese Biotech Incorporation from Nguyen Thi Hong Hai.

December 02, 2019

An undisclosed buyer acquired 5.28% stake in American Vietnamese Biotech Incorporation (HNX:AMV) from Nguyen Thi Hong Hai on November 26, 2019. The buyer acquired 2 million shares of American Vietnamese Biotech Incorporation from Nguyen Thi Hong Hai. Before the transaction, Nguyen Thi Hong Hai was holding 5.2 million shares of American Vietnamese Biotech Incorporation representing 13.7% stake and after the transaction, Nguyen Thi Hong Hai holds 3.2 million shares of American Vietnamese Biotech Incorporation representing 8.42% stake. An undisclosed buyer completed the acquisition of 5.28% stake in American Vietnamese Biotech Incorporation (HNX:AMV) from Nguyen Thi Hong Hai on November 26, 2019.

Latest news about American Vietnamese Biotech Incorporation

American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/23/30	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01/23/01	CI
An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation for VND 29.4 billion.	20/23/20	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2023	05/23/05	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	02/23/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/22/04	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien.	25/22/25	CI
American Vietnamese Biotech Incorporation agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million.	06/21/06	CI
American Vietnamese Biotech Incorporation announced that it has received VND 379.62045 billion in funding from Lotus Investment Management Joint Stock Company and other investors	01/21/01	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	02/21/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	02/20/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	31/20/31	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2020	04/20/04	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	31/20/31	CI
An undisclosed buyer acquired 5.28% stake in American Vietnamese Biotech Incorporation from Nguyen Thi Hong Hai.	02/19/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	31/19/31	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	02/19/02	CI
An undisclosed buyer acquired 8.5% stake in American Vietnamese Biotech Incorporation from Le Anh Hoi.	03/19/03	CI
American Vietnamese Biotech Incorporation announced that it expects to receive VND 280 billion in funding	26/19/26	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2018	17/19/17	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2018	15/19/15	CI

Chart American Vietnamese Biotech Incorporation

Duration

Period

Chart American Vietnamese Biotech Incorporation

More charts

Company Profile

American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AMERICAN VIETNAMESE BIOTECH INCORPORATION	-7.69%	1.8Cr
ELI LILLY AND COMPANY	+38.69%	72TCr
NOVO NORDISK A/S	+34.28%	59TCr
JOHNSON & JOHNSON	-4.49%	37TCr
MERCK & CO., INC.	+20.24%	33TCr
ABBVIE INC.	+2.12%	28TCr
ASTRAZENECA PLC	+17.02%	24TCr
NOVARTIS AG	+9.31%	21TCr
ROCHE HOLDING AG	-5.07%	21TCr
PFIZER, INC.	-0.35%	17TCr